相关实验视频
Updated: Jul 5, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
2017-2021年,超过2万2000名患有1型糖尿病的儿童和成人使用胰岛素:一项多中心观察性研究
Kajal Gandhi1, Osagie Ebekozien2,3, Nudrat Noor2
1Nationwide Children's Hospital, Columbus, OH.
概括
在1型糖尿病中,胰岛素的使用正在增加,并且与更好的A1C控制和更少的急性事件有关,特别是在持续血糖监测 (CGM) 中. 对这种糖尿病技术的访问需要改进.
科学领域:
- 内分泌学和新陈代谢学
- 糖尿病 技术 技术
- 公共卫生 公共卫生
背景情况:
- 1型糖尿病的管理依赖于有效的胰岛素输送和葡萄糖监测.
- 胰岛素治疗和持续血糖监测 (CGM) 是先进的糖尿病技术.
- 了解技术采用的趋势和差异对于公平的护理至关重要.
研究的目的:
- 分析1型糖尿病患者大队伍中胰岛素使用趋势.
- 调查胰岛素使用,血糖控制 (A1C) 和急性糖尿病相关事件之间的关联.
- 检查联合胰岛素和CGM使用对健康结果的影响.
主要方法:
- 分析了一大批1型糖尿病患者的纵向队列.
- 评估胰岛素利用模式的时间.
- 统计评估胰岛素使用,CGM使用,A1C水平,糖尿病酸性糖尿病和严重低血糖之间的关系.
主要成果:
- 胰岛素的利用率随着时间的推移而增加,因性别,保险和种族/种族而有所不同.
- 胰岛素的使用与A1C的改善,CGM采用率的增加以及糖尿病酸和严重低血糖症的降低率有关.
- 与单独使用相比,使用胰岛素和CGM的患者经历的急性事件较少.
结论:
- 胰岛素治疗,特别是与CGM相结合时,与1型糖尿病的更好的临床结果有关.
- 在获得糖尿病技术方面的差异仍然存在,需要有针对性的干预措施.
- 改善接入需要提供者参与,多学科的护理,并解决健康不平等问题,以确保更广泛地采用有益的糖尿病技术.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
175
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
175
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin Formulations: Types and Delivery
197
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
197
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K

